Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1998-04-20
2000-02-22
Kulkosky, Peter F.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
424722, A61K 910, A61K 3156
Patent
active
060280654
ABSTRACT:
A novel oral pharmaceutical composition in the form of a stable flocculated suspension in water is described as comprising: megestrol acetate; at least one compound selected from the group consisting of polyethylene glycol, propylene glycol, glycerol, and sorbitol; and a surfactant, wherein polysorbate and polyethylene glycol are not simultaneously present.
REFERENCES:
patent: 3356573 (1967-12-01), Kirk et al.
patent: 4370321 (1983-01-01), Greaney et al.
patent: 4396615 (1983-08-01), Petrow et al.
patent: 4666885 (1987-05-01), Labrie
patent: 4760053 (1988-07-01), Labrie
patent: 4775661 (1988-10-01), Labrie
patent: 5338732 (1994-08-01), Atzinger et al.
Chao James C.
Femia Robert A.
Ragunathan Narayan
Ross Malcolm S. F.
Kulkosky Peter F.
Pharmaceutical Resources Inc.
LandOfFree
Flocculated suspension of megestrol acetate does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Flocculated suspension of megestrol acetate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Flocculated suspension of megestrol acetate will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-520653